Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 10, 2007, Pages

  Liu, Chen Hua ^a   Hsu, Shih Jer ^a   Lin, Jou Wei ^a   Hwang, Juey Jen ^a   Liu, Chun Jen ^a   Yang, Pei Ming ^a   Lai, Ming Yang ^a,b   Chen, Pei Jer ^a,b   Chen, Jun Herng ^a   Kao, Jia Horng ^a,b   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HEPATIC DOPPLER IMPEDANCE INDEX; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PORTAL VEIN; REPRODUCIBILITY; SPLENIC ARTERIAL PULSATILITY INDEX; SPLENIC DOPPLER IMPEDANCE INDEX; VALIDATION PROCESS;

EID: 84984535854     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.07.017     Document Type: Article

References (46)

1. National Institutes of Health. Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26 (1997) S2-S10
2. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
3. Yano M., Kumada H., Kage M., et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 23 (1996) 1334-1340
4. de Franchis R., Pascal J.P., Ancona E., et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 15 (1992) 256-261
5. Daniele B., Bencivenga A., Megna A.S., et al. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127 (2004) S108-S112
6. Heathcote E.J., Shiffman M.L., Cooksley W.G., et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343 (2000) 1673-1680
7. Piccinino F., Sagnelli E., Pasquale G., et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2 (1986) 165-173
8. Nord H.J. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques-a review. Gastrointest Endosc 28 (1982) 102-104
9. Garcia-Tsao G., and Boyer J.L. Outpatient liver biopsy: how safe is it?. Ann Intern Med 118 (1993) 150-153
10. Cadranel J.F., Rufat P., and Degos F. Practice of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32 (2000) 477-481
11. McGill D.B., Rakela J., Zinsmeister A.R., et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99 (1990) 1396-1400
12. Maharaj B., Maharaj R.J., Leary W.P., et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1 (1986) 523-525
13. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
14. Colloredo G., Guido M., Sonzogni A., et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
15. Fontana R.J., and Lok A.S. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 36 (2002) S57-S64
16. Sheth S.G., Flamm S.L., Gordon F.D., et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 93 (1998) 44-48
17. Giannini E., Risso D., Botta F., et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 163 (2003) 218-224
18. Imbert-Bismut F., Ratziu V., Pieroni L., et al., MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
19. Poynard T., and Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 4 (1997) 199-208
20. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
21. Forns X., Ampurdanes S., Llovet J.M., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
22. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
23. Rosenberg W.M., Voelker M., Thiel R., et al., European Liver Fibrosis Group. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
24. McHutchison J.G., Blatt L.M., de Medina M., et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 15 (2000) 945-951
25. Leroy V., Monier F., Bottari S., et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99 (2004) 271-279
26. Yang P.M., Yang P.J., Huang G.T., et al. Doppler ultrasound in evaluating the hemodynamics of portal vein in patients with chronic liver diseases. J Med Ultrasound 3 (1995) 129-133
27. Gaiani S., Gramantieri L., Venturoli N., et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis?. A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 27 (1997) 979-985
28. Koda M., Murawaki Y., Kawasaki H., et al. Portal blood velocity and portal blood flow in patients with chronic viral hepatitis: relation to histological liver fibrosis. Hepatogastroenterology 43 (1996) 199-202
29. Sarcerdoti D., Merkel C., Bolognesi M., et al. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis; relationship with portal hemodynamics. Gastroenterology 108 (1995) 1152-1158
30. Schneider A.W., Kalk J.F., and Klein C.P. Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol 30 (1999) 876-881
31. Piscaglia F., Gaiani S., Calderoni D., et al. Influence of liver fibrosis on hepatic artery Doppler resistance index in chronic hepatitis of viral origin. Scand J Gastroenterol 36 (2001) 647-652
32. Bolognesi M., Sacerdoti D., Merkel C., et al. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. Hepatology 23 (1996) 1035-1040
33. Liu C.H., Lin J.W., Tsai F.C., et al. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 26 (2006) 1087-1094
34. Bolognesi M., Sacerdoti D., Merkel C., et al. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color Doppler. Ultrasound Med Biol 27 (2001) 901-907
35. Lim A.K., Patel N., Eckersley R.J., et al. Can Doppler sonography grade the severity of hepatitis C-related liver disease?. AJR Am J Roentgenol 184 (2005) 1848-1853
36. Aube C., Winkfield B., Oberti F., et al. New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol 16 (2004) 743-751
37. Bernatik T., Strobel D., Hahn E.G., et al. Doppler measurements: a surrogate marker of liver fibrosis?. Eur J Gastroenterol Hepatol 14 (2002) 383-387
38. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
39. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
40. Debongnie J.C., Pauls C., Fievez M., et al. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 22 (1981) 130-135
41. Sandford N.L., Walsh P., Matis C., et al. Is ultrasonography useful in the liver assessment of diffuse parenchymal liver disease?. Gastroenterology 89 (1985) 186-191
42. Lin D.Y., Sheen I.S., Chiu C.T., et al. Ultrasonographic changes of early cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 21 (1993) 303-308
43. Piscaglia F., Gaiani S., Zironi G., et al. Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis. Ultrasound Med Biol 23 (1997) 675-682
44. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
45. Sacerdoti D., Gaiani S., Buonamico P., et al. Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. J Hepatol 27 (1997) 986-992
46. Hastie T., Tibshirani R., and Friedman J. The element of statistical learning; data mining, inference and prediction (2001), Springer-Verlag, New York